Grail (GRAL) | Financial Analysis & Statements
Grail Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
43.6M
Gross Profit
-11.1M
-25.54%
Operating Income
-124.4M
-285.37%
Net Income
-99.2M
-227.48%
EPS (Diluted)
$-2.44
Balance Sheet Metrics
Total Assets
2.9B
Total Liabilities
344.2M
Shareholders Equity
2.6B
Debt to Equity
0.13
Cash Flow Metrics
Operating Cash Flow
-64.6M
Free Cash Flow
-63.9M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Grail Income Statement From 2019 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2019 |
|---|---|---|---|---|---|
| Revenue | 147.2M | 125.6M | 93.1M | 55.6M | 0 |
| Cost of Goods Sold | 209.7M | 203.6M | 188.7M | 172.0M | - |
| Gross Profit | -62.6M | -78.0M | -95.6M | -116.4M | - |
| Gross Margin % | -42.5% | -62.1% | -102.7% | -209.6% | 0.0% |
| Operating Expenses | |||||
| Research & Development | 195.8M | 322.4M | 338.7M | 329.6M | 167.1M |
| Selling, General & Administrative | 275.8M | 367.8M | 362.6M | 296.4M | 88.6M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 471.6M | 690.2M | 701.3M | 626.0M | 255.7M |
| Operating Income | -534.2M | -768.2M | -796.9M | -742.5M | -255.7M |
| Operating Margin % | -363.0% | -611.7% | -855.9% | -1,336.6% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | 28.7M | 26.7M | 8.0M | 1.7M | 12.4M |
| Interest Expense | - | - | - | - | - |
| Other Non-Operating Income | -29.0M | -1.4B | -718.7M | -4.7B | -1.8M |
| Pre-tax Income | -534.5M | -2.2B | -1.5B | -5.4B | -245.0M |
| Income Tax | -126.2M | -135.4M | -224.0M | -42.3M | -195.0K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -408.4M | -2.0B | -1.3B | -5.4B | -244.9M |
| Net Margin % | -277.5% | -1,613.9% | -1,378.7% | -9,719.3% | 0.0% |
| Key Metrics | |||||
| EBITDA | -349.8M | 810.8M | 80.2M | 4.1B | -245.4M |
| EPS (Basic) | $-11.11 | $-63.54 | $-41.34 | $-173.87 | $-7.89 |
| EPS (Diluted) | $-11.11 | $-63.54 | $-41.34 | $-173.87 | $-7.89 |
| Basic Shares Outstanding | 36753751 | 31901259 | 31052632 | 31052632 | 31052632 |
| Diluted Shares Outstanding | 36753751 | 31901259 | 31052632 | 31052632 | 31052632 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Grail Balance Sheet From 2019 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2019 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 249.7M | 214.2M | 97.3M | 241.6M | 143.2M |
| Short-term Investments | 654.7M | 549.2M | - | - | 401.2M |
| Accounts Receivable | 18.3M | 20.3M | 16.9M | 15.3M | - |
| Inventory | 16.0M | 18.6M | 21.7M | 19.8M | - |
| Other Current Assets | 15.1M | - | 20.1M | 18.7M | 12.6M |
| Total Current Assets | 953.8M | 819.9M | 156.1M | 295.6M | 557.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 106.2M | 119.9M | 84.4M | 104.7M | 35.0M |
| Goodwill | 1.9B | 2.0B | 4.5B | 5.9B | - |
| Intangible Assets | 1.9B | 2.0B | 2.7B | 2.9B | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 13.7M | 11.1M | 12.2M | 10.7M | 4.6M |
| Total Non-Current Assets | 2.0B | 2.2B | 3.8B | 4.6B | 78.0M |
| Total Assets | 2.9B | 3.0B | 3.9B | 4.9B | 635.5M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 2.1M | 4.8M | 18.8M | 15.2M | 5.9M |
| Short-term Debt | 11.7M | 13.3M | 14.8M | 13.3M | 4.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.9M | 1.6M | 809.0K | 3.1M | 2.7M |
| Total Current Liabilities | 79.7M | 76.9M | 163.6M | 134.9M | 44.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 43.1M | 54.9M | 69.6M | 82.7M | 36.6M |
| Deferred Tax Liabilities | 218.6M | 345.9M | 32.9M | 71.1M | - |
| Other Non-Current Liabilities | 2.8M | 2.2M | 1.5M | 3.1M | 3.1M |
| Total Non-Current Liabilities | 264.5M | 403.0M | 104.0M | 156.9M | 1.8B |
| Total Liabilities | 344.2M | 479.9M | 267.6M | 291.8M | 1.8B |
| Equity | |||||
| Common Stock | 40.0K | 34.0K | - | - | 138.0K |
| Retained Earnings | -10.2B | -9.8B | -7.8B | -6.3B | -1.3B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.6B | 2.5B | 3.6B | 4.6B | -1.2B |
| Key Metrics | |||||
| Total Debt | 54.9M | 68.1M | 84.4M | 96.0M | 41.2M |
| Working Capital | 874.2M | 742.9M | -7.5M | 160.7M | 512.6M |
Balance Sheet Composition
Grail Cash Flow Statement From 2019 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2019 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -408.4M | -2.0B | -1.5B | -5.4B | -244.9M |
| Depreciation & Amortization | 156.3M | 158.1M | 158.7M | 154.8M | 10.3M |
| Stock-Based Compensation | 58.3M | 86.1M | 97.2M | 75.7M | 28.4M |
| Working Capital Changes | 2.6M | -13.2M | 6.3M | -15.5M | -4.7M |
| Operating Cash Flow | -315.9M | -2.0B | -1.3B | -5.3B | -210.9M |
| Investing Activities | |||||
| Capital Expenditures | -909.0K | -5.2M | -12.9M | -22.9M | -3.2M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -1.3B | -545.8M | 0 | 0 | -551.5M |
| Investment Sales | 1.2B | - | 0 | 0 | 687.8M |
| Investing Cash Flow | -85.0M | -551.0M | -12.9M | -22.9M | 133.0M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | -1.6M |
| Financing Cash Flow | 418.8M | 1.2B | 463.8M | 604.8M | 157.3M |
| Free Cash Flow | -299.9M | -582.4M | -608.7M | -584.2M | -249.1M |
| Net Change in Cash | 17.8M | -1.3B | -864.8M | -4.7B | 79.5M |
Cash Flow Trend
Grail Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-4.56
Forward P/E
-6.06
Price to Book
0.80
Price to Sales
14.23
PEG Ratio
0.29
Profitability Ratios
Profit Margin
-277.46%
Operating Margin
-285.37%
Return on Equity
-16.07%
Return on Assets
-11.31%
Financial Health
Current Ratio
11.97
Debt to Equity
2.13
Per Share Data
EPS (TTM)
$-11.11
Book Value per Share
$63.92
Revenue per Share
$4.00
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GRAL | 2.1B | -4.56 | 0.80 | -16.07% | -277.46% | 2.13 |
| Thermo Fisher | 174.6B | 25.84 | 3.31 | 13.52% | 15.15% | 82.91 |
| Danaher | 126.4B | 34.61 | 2.40 | 7.08% | 14.89% | 37.17 |
| Revvity | 9.7B | 45.77 | 1.46 | 3.22% | 8.45% | 46.87 |
| Icon plc | 9.0B | 15.52 | 0.94 | 6.27% | 7.40% | 38.26 |
| Charles River | 8.3B | 681.33 | 2.61 | -4.23% | -3.60% | 81.95 |
Financial data is updated regularly. All figures are in the company's reporting currency.





